Pulmonary function, cardiac function, and exercise capacity in a follow- up of patients with congestive heart failure treated with carvedilol

American Heart Journal

Volumn 138, Issue 3 I, 1999, Pages 460-467

  Guazzi, M ^a   Agostani, P ^a   Matturri, M ^a   Pontone, G ^a   Guazzi, M D ^a  

^a Istituto di Cardiologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL;

ADULT; ANAEROBIC THRESHOLD; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HEART EJECTION FRACTION; HEART LEFT VENTRICLE PERFORMANCE; HEART STROKE VOLUME; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MALE; PRIORITY JOURNAL; TOTAL LUNG CAPACITY; TREATMENT OUTCOME;

EID: 0032845314     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70148-1     Document Type: Article

References (30)

1. Naum C, Sciurpa FC, Rogers RM. Pulmonary function abnormalities in chronic severe cardiomyopathy preceding cardiac transplantation. Am Rev Resp Dis 1992;145:1334-8.
2. Puri S, Baker BL, Dutka DP, Oakley CM, Hughes JMB, Cleland JGF. Reduced alveolar-capillary diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance. Circulation 1995;91:2769-74.
3. Guazzi M, Marenzi G, Alimento M, Contini M, Agostoni P. Improvement in alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation 1997;1930-6.
4. Hosenpud JD, Stibolt TA, Atwal K, Shelley D. Abnormal pulmonary function specifically related to congestive heart failure: comparison of patients before and after cardiac transplantation. Am J Med 1990;88:493-6.
5. Marzo KP, Wilson JR, Mancini DM. Effects of cardiac transplantation on ventilatory response to exercise. Am J Cardiol 1992;69:547-53.
6. Ohar J, Osterloh J, Ahmed N, Miller L. Diffusing capacity decreases after heart transplantation. Chest 1993;103:857-61.
7. Fink LI, Wilson JR, Ferraro N. Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure. Am J Cardiol 1986;57:249-53.
8. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburrn PA, Eichhorn EJ. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol 1995;25:1154-61.
9. Packer M, Colucci WS, Sackner-Bernstein JD, Liang C, Goldscher DA, Freeman I, et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The Precise trial. Circulation 1996;94:2793-9.
10. Gilbert EM, Abraham WT, Olsen S, Hattler B, White M, Mealy P, et al. Comparative hemodynamic, left ventricular functional and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation 1996;94:2817-25.
11. Australia/New Zeland Heart Failure Research Collaboration Group. Randomized placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 1997; 349:375-80.
12. Metra M, Nardi M, Giubbini R, Dei Cas L. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1994;24:1678-87.
13. Pfeffer MA, Stevenson LW. β-adrenergic blockers and survival in heart failure. N Engl J Med 1996;334:1396-7.
14. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
15. Krum H, Sackner-Bernstein JD, Goldsmith RL, Kukin ML, Schwartz B, Penn J, et al. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 1995;92:1499-506.
16. Vantrimpont P, Rouleau JL, Wun CC, Ciampi A, Klein M, Sussex B, et al. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the survival and ventricular enlargement (SAVE) study. J Am Coll Cardiol 1997;29:229-36.
17. Dunn CJ, Lea AP, Walstaff AJ. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs 1997;54:161-85.
18. Pitt B, Chang P, Timmermans PB. Angiotensin II receptor antagonists and design of the evaluation of Losartan in the elderly (ELITE) trial. Cardiovasc Drug Ther 1995;9:693-700.
19. Cotes JE, Dabbs JM, Elwood PC, Hall AM, Mc Donald A, Saunders MJ. Iron deficiency anemia: its effect on transfer factor for the lung (diffusing capacity) and ventilation and cardiac frequency during submaximal exercise. Clin Sci 1972;42:325-35.
20. Roughton FJW, Forster FE. Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in human lung with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J Appl Physiol 1957;11:290-302.
21. Guazzi M, Tamborini G, Maltagliati A. Changes in pulmonary venous return during head-up tilting in man. Clin Sci 1997;93:13-20.
22. Roussvoll O, Hatle LV. Pulmonary venous flow velocities recorded by transthoracic Doppler ultrasound: relation to left ventricular diastolic pressures. J Am Coll Cardiol 1993;21:1687-96.
23. Weber KT, Janicki JS. Cardiopulmonary exercise testing for evaluation of chronic heart failure. Am J Cardiol 1985;55:22A-31A.
24. Costello ML, Matheu Costello O, West JB. Stress failure of alveolar epithelial cells studied by scanning electron microscopy. Am Rev Resp Dis 1992;145:1446-55.
25. Andersson B, Caidahl K, di Lenarda A, Warren SE, Gross F, Waldenstrom A, et al. Changes in early and late diastolic filling patterns induced by long-term adrenergic β-blockade in patients with idiopathic dilated cardiomyopathy. Circulation 1996; 94:673-82.
26. Light RW, George RB. Serial pulmonary function in patients with acute heart failure. Arch Intern Med 1983;143:429-33.
27. Eichhorn EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation 1996;94:2285-96.
28. 2 in regulating cardiac fibroblast collagen turnover. Am J Cardiol 1995;76:8D-13D.
29. O'Rourke RA. Beta-adrenergic blocking agents or angiotensin-converting enzyme inhibitors, or both, for postinfarction patients with left ventricular dysfunction. J Am Coll Cardiol 1997;29:237-9.
30. Moore DP, Weston AR, Hughes JMB, Oakley CM, Cleland JGF. Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure. Lancet 1992;339:850-3.